Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
902 people get ENDP articles and Market Currents by email alert.
Get email alerts on ENDP »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
PR Newswire (May 7, 2013)
-
-
-
PR Newswire (Apr 15, 2013)
-
-
-
-
-
-
-
PR Newswire (Mar 5, 2013)
-
-
-
PR Newswire (Feb 28, 2013)
-
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
-
-
-
'Trouble Is Opportunity' - Endo Fallout Is Worth A LookPropThink • Thu, Dec 13, 2012
-
-
-
-
-
Endo Pharma Looking for ActionZacks Investment Research • Wed, May 18, 2011 -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
5 Healthcare Companies With Recent Insider BuyingMarkus Aarnio • Thu, Nov 15, 2012 -
-
-
-
-
-
-
Fund Holdings For 3 Healthcare Stocks, And 4 Other SellsGuruFundPicks • Mon, Jun 18, 2012
-
Endo Pharmaceuticals Holdings Inc. Q1 2009 Earnings Call TranscriptWed, Apr 29, 2009
-
Endo Pharmaceuticals Holdings, Inc. Q4 2008 Earnings Call TranscriptFri, Feb 27, 2009
-
Endo Pharmaceuticals Holdings, Inc. Q2 2008 Earnings CallThu, Jul 31, 2008
-
Endo Pharmaceuticals Holdings, Inc. Q1 2008 Earnings Call TranscriptWed, Apr 30, 2008
-
Endo Pharmaceuticals Holdings, Inc. Q4 2007 Earnings Call TranscriptSun, Feb 24, 2008
-
Endo Pharmaceuticals Holdings Inc. Q3 2007 Earnings Call TranscriptFri, Nov 2, 2007
-
PR Newswire (May 7, 2013)
-
PR Newswire (Apr 15, 2013)
-
PR Newswire (Mar 5, 2013)
-
PR Newswire (Feb 28, 2013)
-
PR Newswire (Feb 25, 2013)
-
PR Newswire (Feb 13, 2013)
-
at CNBC.com (Jan 3, 2013)
-
PR Newswire (Dec 19, 2012)
-
PR Newswire (Dec 12, 2012)
-
PR Newswire (Nov 30, 2012)
-
at CNBC.com (Nov 22, 2012)
-
at CNBC.com (Nov 21, 2012)
-
PR Newswire (Nov 8, 2012)
-
PR Newswire (Nov 7, 2012)
-
PR Newswire (Nov 5, 2012)
-
PR Newswire (Oct 22, 2012)
ENDP vs. ETF Alternatives
Company Description
We are a specialty pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of branded and generic prescription pharmaceuticals used primarily to treat and manage pain, overactive bladder, prostate and bladder cancer, and the early onset of puberty in... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Monday, May 13, 12:20 PM Endo Health Solutions (ENDP -2.6%) appears to have stabilized today, albeit lower, following a couple of trading halts on volatility just prior to Friday's close after the FDA denied its petition to halt generic competition to its painkiller Opana ER on safety grounds. The ruling will mean a big hit to earnings next quarter, and likely lead exploring options to mitigate the damage. Jefferies says the FDA was wrong, and acted "irrationally inconsistent" in its decision. Nonetheless, the firm lowers its price target on the shares from $47.00 to $37.00. Comment! [Healthcare, On the Move, Earnings]
- Tuesday, May 7, 4:02 PM Endo Health (ENDP +0.8%) is set to finish in the green today, despite posting a mixed Q1. Net earnings swung to a profit amid fewer write-downs and other items, as well as a modest revenue increase on strong generic sales growth. Generic sales +23% at $178M, while branded-pharmaceutical sales declined 2% to $358M. Lidoderm sales dropped 11%, mostly owing to its supply agreement with Actavis (ACT). Sales of Opana ER slumped 31% as sales continue to lag following a disruption early last year resulting from the closing of a Novartis (NVS) plant. Comment! [Healthcare, Earnings]
- Tuesday, May 7, 7:03 AM Endo Health (ENDP): Q1 EPS of $1.09 beats by $0.01. Revenue of $709M (+3% Y/Y) misses by $28.79M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Tuesday, May 7, 12:05 AM Notable earnings before Tuesday’s open: ACM, AFAM, AKRX, ALLT, ARCC, ARIA, BCRX, CHTR, CMLP, CNK, CQB, CRZO, CVLT, DFT, DISCA, DTV, DWRE, EMR, ENDP, FE, FOSL, HCN, HFC, HPT, HSIC, KWK, LPX, NRG, NRGY, NVAX, OAK, OMX, PQ, PRGO, RIGL, SHOO, TA, TAP, TDG, TGH, TICC, TRGT, TW, WRES, XEC 2 Comments [Earnings]
- Monday, May 6, 5:30 PM Notable earnings before Tuesday's open: ACM, AFAM, AKRX, ALLT, ARCC, ARIA, BCRX, CHTR, CMLP, CNK, CQB, CRZO, CVLT, DFT, DISCA, DTV, DWRE, EMR, ENDP, FE, FOSL, HCN, HFC, HPT, HSIC, KWK, LPX, NRG, NRGY, NVAX, OAK, OMX, PQ, PRGO, RIGL, SHOO, TA, TAP, TDG, TGH, TICC, TRGT, TW, WRES, XEC Comment! [Earnings]
- Thursday, February 28, 5:05 PM Endo Health (ENDP): Q4 EPS of $1.62 beats by $0.08. Revenue of $801M misses by $6.98M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Thursday, February 28, 12:10 AM Notable earnings after Thursday’s close: AIRM, AL, ALSK, BID, CLNE, CPNO, CRM, DECK, DRH, ENDP, GPS, GXP, HTGC, JOE, KOG, KYAK, MCP, MDR, MDVN, MENT, MTZ, MXWL, NGD, NOG, OPTR, OVTI, PANW, RNDY, RST, SD, SLXP, SONS, SPLK, SSRI, TEG, TESO, UHS, WR, XTEX, YOKU Comment! [Earnings]
- Wednesday, February 27, 5:35 PM Notable earnings after Thursday’s close: AIRM, AL, ALSK, BID, CLNE, CPNO, CRM, DECK, DRH, ENDP, GPS, GXP, HTGC, JOE, KOG, KYAK, MCP, MDR, MDVN, MENT, MTZ, MXWL, NGD, NOG, OPTR, OVTI, PANW, RNDY, RST, SD, SLXP, SONS, SPLK, SSRI, TEG, TESO, UHS, WR, XTEX, YOKU 1 Comment [Earnings]
- Friday, January 4, 10:53 AM Endo Health Solutions (ENDP -4.5%) trades lower after cutting its 2013 guidance yesterday due to higher charges related to its core painkiller franchise and generic-drug business. It now expects its EPS to be within a range of $4.40 to $4.70 a share, down from earlier projections of $5.20 to $5.40. Revenue is projected between $2.8B to $2.95B, below previous estimates of $3B to $3.2B. Piper Jaffray cut the shares to Neutral on the news, and lowers its price target to $28. Comment! [Healthcare, Earnings, On the Move]
- Monday, November 5, 2012, 7:07 AM Endo Pharmaceuticals (ENDP): Q3 EPS of $1.28 beats by $0.02. Revenue of $750.5M (-1% Y/Y) misses by $38M. (PR) Comment! [Earnings, Healthcare]
- Monday, November 5, 2012, 12:05 AM Notable earnings before Monday’s open: ANV, ARCC, BPI, CHD, CYOU, ENDP, ETR, HNT, HUM, ICE, LBTYA, MTW, NNN, PCYC, RIG, ROK, SLW, SO, SOHU, SYY, TEL, TSLA, TWC Comment! [Earnings]
- Sunday, November 4, 2012, 5:30 PM Notable earnings before Monday’s open: ANV, ARCC, BPI, CHD, CYOU, ENDP, ETR, HNT, HUM, ICE, LBTYA, MTW, NNN, PCYC, RIG, ROK, SLW, SO, SOHU, SYY, TEL, TSLA, TWC Comment! [Earnings]
- Tuesday, August 7, 2012, 7:16 AM Endo Pharmaceuticals (ENDP): Q2 EPS of $1.27 misses by $0.09. Revenue of $785M (+29% Y/Y) beats by $10M. (PR) Comment! [Earnings, Healthcare]
- Tuesday, August 7, 2012, 12:05 AM Notable earnings before Tuesday’s open: AKRX, AMRC, APU, ARCC, ARCO, BPI, CHD, CRZO, CVC, CVS, DWRE, EBIX, EMR, ENDP, EXPD, FE, FOSL, GTE, HL, HPT, KITD, KWK, MEA, MGM, MMC, MNKD, MPEL, NIHD, ODP, PCG, POM, SIRI, SOL, STWD, TAP, THC, TIE Comment! [Earnings]
- Monday, August 6, 2012, 5:30 PM Notable earnings before Tuesday’s open: AKRX, AMRC, APU, ARCC, ARCO, BPI, CHD, CRZO, CVC, CVS, DWRE, EBIX, EMR, ENDP, EXPD, FE, FOSL, GTE, HL, HPT, KITD, KWK, MEA, MGM, MMC, MNKD, MPEL, NIHD, ODP, PCG, POM, SIRI, SOL, STWD, TAP, THC, TIE 1 Comment [Earnings]
- Tuesday, May 1, 2012, 7:43 AM Endo Pharmaceuticals (ENDP): Q1 EPS of $0.87 beats by $0.01. Revenue of $691M (+23.3% Y/Y) misses by $9M. (PR) Comment! [Earnings, Healthcare]
-
The Wall Street Transcript
Endo Health Solutions ($ENDP) Revenue to Shrink due to Lidoderm and Opana ER Generic Competition- http://su.pr/2Sx3Rf - View all 0 replies
-
Ryan Mallory
Fuinhaz Setups for April 17 2013 | $ARMH $ASML $ENDP $VVUS | SharePlanner http://bit.ly/12mdW8S - View all 0 replies
-
Red Acre Investments
just published part 1 of our April Biotech binary event watch : http://bit.ly/ZmquIg $AGN, $THRX, $ENDP, $SCMP, $GILD - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
MagicDiligence
Stocks moving in and out of Magic Formula Investing this week. $ENDP $JOY $LMCA and others. http://bit.ly/13SLtrK - View all 0 replies
-
MagicDiligence
Stocks moving in and out of Magic Formula Investing this week $GCI $ENDP $LMT and others http://bit.ly/WdYF9o - View all 0 replies
-
- View all 0 replies
-
MagicDiligence
Been a while since Endo Health $ENDP has been in MFI. Diversified but smaller hlthcare firm - branded, generic, now devices. Worth a look. - View all 0 replies
-
- View all 0 replies
LATEST REPLIES
-
- View all 2 replies
-
-